TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Dietary behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude Scale Towards Diet Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline on the Functional Dyspepsia Scale (FD) at 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline on the Irritable Bowel Syndrome Scale (IBS) at 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline on the Gastroesophageal Reflux Disease Questionnaire (GERDQ) at 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: clinically significant changes from baseline in electrocardiogram (ECG), vital signs, spirometry and safety laboratory assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depressive symptoms (HAMD-17)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in severity of illness (CGI-S)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in depressive symptoms (MADRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in insomnia symptoms (ISI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of cortical vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of nidus vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: IBD Disability Index (IBD-DI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants with criteria of severe COPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence of CS niche (CS defect)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Reception Threshold (SRT) in dB SNR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of surgical delays
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Abnormal laboratory findings of clinical significance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative recovery of total radioactivity in excreta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage of metabolite in total exposure AUC in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: maximum concentrations (Cmax) for total plasma radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Food Allergy Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: de novo GERD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Overall accuracy for biometric parameters measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall accuracy for amniotic fluid volume assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time for the occurrence of Grade 2 radiation-induced oral mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HBAIC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maintained remission of EoE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma BK viral load change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in ocular discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in visual fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from baseline in computer vision symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in symptoms of computer vision syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Reported Outcome Measure (PROM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acute G3 or higher Gastrointestinal Toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Acute G3 or higher Genitourinary Toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative pain score on rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of 68Ga-FAPI PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of PSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants selecting the plant-based meal
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Distribution of bioimpedance vector
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social-emotional competence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cmax of IDX-1197
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast of IDX-1197
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fovea avascular zone FAZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of PTSD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission of PTSD diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Propofol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of kidney failure or renal death
Endpoint domain: Mortality/survival
Primary endpoint: Time to first occurrence of Cardiovascular death or non-fatal CV event
Endpoint domain: Mortality/survival
Primary endpoint: Change in participants' knowledge about osteoporosis
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quantification of Trimethylamine N-oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Apixaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Area Under the Curve AUC(0 to 36hr, AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS-CoV-2 viral load decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: In-hospital mortality (all cause)
Endpoint domain: Mortality/survival
Primary endpoint: Mortality at long-term follow-up
Endpoint domain: Mortality/survival
Primary endpoint: Satisfaction of the virtual serious game
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of the virtual serious game
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Clinical knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome of rhino-orbital mucormycosis
Endpoint domain: Mortality/survival
Primary endpoint: Anesthetic acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Procedural satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Organ function status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in nurses perception of ethical decision making climate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: blood glucose and lipids level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall trainee's competence rate
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency of elementary lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: intra-operative CBG level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of CRBD
Endpoint domain: Adverse events/effects
Primary endpoint: Memory and learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: level of post-operative thirst
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eating Disorders Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: incidence of grade ≥3 Neutrophil count decreased
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Freedom from major adverse device events (MADE)
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from symptom-driven target lesion reintervention (TLR)
Endpoint domain: Adverse events/effects
Primary endpoint: Detection and visualization of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Comprehension in noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to correctly visually estimate LVEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of Problematic Internet Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assessment of static and dynamic balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of concentration and attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of adherence to follow up recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: accuracy of intra-operative high-resolution surgical specimen PET-CT in determining margin status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to control of agitation and delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant Accrual and Dropout Rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Engagement with Intervention
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: mRNA transcript levels for genes expressed according to white blood cell type after flu vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-flu antibody titers in response to vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hospital-free days at 30-days post-randomization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Migraine frequency or severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Financial wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Food Security
Endpoint domain: Life impact
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Change in TAPSE/PASP coupling measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in daily accelerometer measured activity (steps)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vital capacity (Voldyne 5000)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety assessment by adverse event monitoring
Endpoint domain: Adverse events/effects
Primary endpoint: Therapeutic alliance
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Perceived quality of care- therapists
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Levels of anti-SARS-CoV-2 spike protein humoral immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CNS control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of recurrences
Endpoint domain: Mortality/survival
Primary endpoint: Feasibility of manufacturing Ide-Cel
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intraoperative hemodynamic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Differences in the percentages of eosinophils expressing activation-related molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression levels of activation markers on eosinophils membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difference in planned and achieved alignment in degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in the visual analogue scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Significant difference in length of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Bronchiectasis exacerbation times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in nasal tip projection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Columella height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in projection alar length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle connective protein synthesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Usability Rating Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Agreement in wheal size measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of malignant disease from biliary system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: quality of walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: selective motor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensory processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: objective sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Proportion of subjects with the same or reduced ADAS-cog14 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Confirmed Objective Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Immune Mediated Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 6 Minute Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Existence of pathological Prion Protein (PrP) in CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Acute GU and GI toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Perception of the parental role
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Parenting practices (Authoritative parenting style)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Parenting practices (Overreactivity and Laxness)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: osteophyte diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: hyaline cartilage thickness assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Young's modulus quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Dryness Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tongue pressure (MTP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of clinically significant abnormal findings in 12-lead electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Columbia-Suicide Severity Rating Scale (C-SSRS) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adhesion score at third-look hysteroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fugl Meyer Motor Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Donor site re-epithelization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Level of Furin protein in the blood of hospitalized patients with SARS-CoV2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Level of Furin protein in the blood of outpatient patients with SARS-CoV2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Level of Furin protein in the blood of vaccinated individuals against SARS-CoV2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum tolerated dose/Recommended Phase Ⅱ Dose (MTD/RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants who no longer fulfill the Rome IV constipation criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Radiologic liver parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of familial hypercholesterolemia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cascade screening of 1st degree family members
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: % patients with changed asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in asthma exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic Post-op Hip Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerated fraction dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in factor nuclear kappaB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in intestinal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Levels of Tenascin C, IL-1β, IL-4 and IL-6 saliva samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of subjects with Adverse Events (all and serious)
Endpoint domain: Adverse events/effects
Primary endpoint: Complications related to implantation surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Incidences of adjacent segment degeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Waist - to - Hip ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes scores of Montreal Cognitive Assessment (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change scores of Amsterdam Instrumental Activities of Daily Living Questionnaire, Short Version
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change scores of Lawton Instrumental Activities of Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: COMFORT Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time in hospital during 30 days after admission to the ED
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Psychological Empowerment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotion Management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety of FT538 monotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of administering FT538 monotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contour of Class 2 composite restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of device related Major Adverse Events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Matsuda Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic profiling of urine samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic profiling of serum samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Disease control in BPH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with complete remission of ocular involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with successful LV lead location
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum Galectin-3 Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes